Interestingly, we observed an increase in mesenchymal signature genes, such as the adhesion molecule CD44, the PDGF receptor beta, or PPRX, and an increase in the BRCA tumor suppressor and a decrease in some classical progenitor markers, such as prominin-1 or CSMD3. This evidence concerns the gene CSMD3 and neoplasm.